New Method Using DNA Nanoballs to Revolutionize Pathogen Detection
|
By LabMedica International staff writers Posted on 08 Sep 2023 |
|
Throughout the recent COVID-19 pandemic, protein-based diagnostics played a significant role in rapid testing. However, developing high-quality antibodies for these methods is time-consuming. In contrast, nucleic acid-based approaches offer advantages in terms of development ease, sensitivity, and flexibility. Scientists have now pioneered a novel technique using DNA Nanoballs for pathogen detection that could simplify nucleic acid testing and revolutionize pathogen identification. Their research could pave the way for a simple electronic-based test to quickly and affordably identify various nucleic acids in diverse scenarios.
The methodology developed by researchers at Karolinska Institute (Stockholm, Sweden) combined Molecular Biology (specifically DNA Nanoball generation) with electronics (electric impedance-based quantification) to create this groundbreaking detection tool. They are cautiously optimistic about its potential to identify a range of pathogenic agents in real-world settings. The team modified an isothermal DNA amplification reaction called LAMP to produce tiny DNA nanoballs measuring 1-2μM if the pathogen was present in the sample. These nanoballs are then guided through tiny channels and electrically identified as they pass between two electrodes. The method has demonstrated impressive sensitivity, capable of detecting as few as 10 target molecules, and provides rapid results in under an hour using a compact, stationary system.
This label-free detection method has the potential to accelerate the development of new diagnostic kits. By combining affordable mass-produced electronics with lyophilized reagents, it could become a cost-effective, widely accessible, and scalable point-of-care device. Currently, the research team is actively exploring applications in fields such as environmental monitoring, food safety, virus detection, and antimicrobial resistance testing. They are also considering licensing options and establishing a startup to leverage this technology, having recently applied for a patent.
“Fast and accurate detection of genetic material is key for diagnosis, especially so in response to the emergence of novel pathogens,” said principal investigator Vicent Pelechano.
Related Links:
Karolinska Institute
Latest Molecular Diagnostics News
- AI Tool Predicts Immunotherapy Response Using Tumor Senescence Signals
- New Variant Tracking Option Expands Molecular Residual Disease Monitoring
- Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging
- Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis
- GeneDx Presents Evidence for Wider Clinical Use of Genomic Sequencing at ASHG 2026
- Clinical Trial Evaluates Liquid Biopsy for Early-Stage Breast Cancer Detection
- RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer
- Modeling Study Shows Blood-Based CRC Screening Could Prevent More Deaths Than Stool Tests
- Noninvasive Cervical Test Detects Endometrial Cancer for Triage
- AI Tool Classifies Pathogenic Variants in Severe Childhood Epilepsy
- Molecular Test Detects Barrett’s Esophagus to Guide Endoscopy Referral
- Blood-Based Metagenomic Test Detects Wide Range of Pathogens from Single Sample
- New RNA Detection Tool Shows Promise for HIV and Other Viral Testing
- Tissue-Specific Vesicle Isolation Expands Molecular Insights Into Liver Disease
- Whole Genome Sequencing Solution Targets Unsolved Rare Disease Cases
- Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer
Channels
Clinical Chemistry
view channel
Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis
Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more
Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment
Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more
Multimodal Platform to Combine Blood and Imaging Biomarkers for Lung Nodule Assessment
Lung nodules are commonly detected during chest imaging and require careful risk assessment to determine whether follow-up imaging, additional testing, or biopsy is needed. With millions of patients evaluated... Read more
Hematology
view channel
New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis
Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read more
Handheld Point-of-Care Test Aims to Enable Rapid Coagulation Assessment in Trauma
Severe blood loss and inadequate tissue oxygenation are leading causes of preventable death after traumatic injury. Blood products are essential in trauma care, but cold-chain storage, short shelf life,... Read more
Immunology
view channel
Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis
Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more
Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia
Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more
Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk
A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more
Longitudinal Blood Testing Reveals Changes in Allergen Sensitization During Childhood
Food allergy is a major childhood health concern, and distinguishing persistent risk from transient sensitization can guide clinical decisions. Specific IgE antibodies may be detectable even when a child... Read moreMicrobiology
view channel
Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response
The ongoing Ebola Bundibugyo outbreak in the Democratic Republic of the Congo and neighboring countries has become one of the largest outbreaks of this Ebola virus species recorded to date.... Read more
Rapid Host-Response Test Aims to Predict Corticosteroid Benefit in Sepsis
Sepsis and severe infections are difficult to treat because patients with similar clinical presentations may have very different underlying immune responses. Corticosteroids are commonly used in severe... Read more
Pathology
view channel
AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps
Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more
AI Pre-Screening Helps Identify Lung Cancer Cases for Additional Biomarker Testing
Tempus AI (Chicago, IL, USA) will present findings from a study evaluating an artificial intelligence (AI)-enabled pre-screening panel for advanced non-small cell lung cancer (NSCLC) at the ESMO Congress... Read more
AI Pathology Platform Targets Workflow Delays and Molecular Test Failures
Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more
Molecular Testing Refines Barrett’s Esophagus Progression Risk Beyond Biopsy Findings
Barrett’s esophagus is a precancerous condition associated with increased risk of esophageal adenocarcinoma. Routine endoscopic biopsy findings guide surveillance and therapy, but histopathology may not... Read moreTechnology
view channel
New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows
Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more
Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Industry
view channel
Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection
Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Alzheimer’s Progression Blood Test Gains U.S. Patent Ahead of Planned Launch
Alzheimer’s disease is the most common cause of dementia, accounting for an estimated 60–70% of cases worldwide. Its progressive effects on memory, thinking, behavior, and daily functioning underscore... Read more
